Asymmetric Synthesis of Cyclic Hydroxy Ketones
Gen er a l P r oced u r e for r-Hyd r oxy Keton es 3, 7, 9, 11,
a n d 13. P r ep a r a tion of (R)-r-Hyd r oxych r om a n on e (3)
fr om 1a . A slurry of K3Fe(CN)6 (1.65 g, 5.0 mmol), Na2S2O8
(8.95 g, 37.5 mmol), K2CO3 (20.8 g, 150 mmol), K2OsO4‚2H2O
(92 mg, 0.25 mmol), CH3SO2NH2 (2.5 g, 26.3 mmol), and
(DHQD)2PHAL (390 mg, 0.50 mmol) in CH3CN (50 mL) and
water (50 mL) was aged at 0 °C for 10 min. To the slurry was
added the methyl enol ether 2a (4.05 g, 25 mmol), and the
mixture was aged overnight at 0 °C. Methyl tert-butyl ether
(MTBE) (50 mL) and 20% brine solution (50 mL) were added,
and the layers were separated. The aqueous layer was back-
extracted with MTBE (50 mL) and the combined organic layers
were washed with 20% brine solution. The organic layer was
dried with Na2SO4 and stripped of solvents to give 3 as a yellow
Con clu sion
We have shown that the Sharpless AD reaction, with
a few modifications, gives R-hydroxyketones from enol
ethers of cyclic ketones, with high enantioselectivity. The
degree of the enantiomeric excess is proportional to the
length of the unbranched enol ether chain, giving opti-
mum enantioselectivity with the pentyl moiety. Branch-
ing of the enol ether chain results in decreased selectivity,
especially with branching at the C1 carbon. These results
led to an efficient scalable synthesis of R-hydroxy chro-
manone (99% yield, 94% ee), a precursor of cis-ami-
nochromanol, an important amino alcohol for the syn-
thesis of vital biologically active compounds. The method
has also been shown to be effective for the production of
other enantiomerically enriched R-hydroxy ketones in-
cluding (R)- and (S)-R-hydroxycyclohexanone, an impor-
tant building block in organic synthesis.
oil (3.65 g, 22.5 mmol). [R]20 +71.25 (CHCl3); SFC retention
D
times, 7.6 min for the (R)-enantiomer and 6.7 min for the (S)-
enantiomer. Isolation of 3 as a white crystalline solid was
achieved by crystallization from ethyl acetate and hexanes.
(6R)-5-Oxo-6,7,8,9-tetr a h yd r o-5H-ben zo[a ][7]a n n u len -
6-yl (2S)-(Meth yloxy)(p h en yl)eth a n oa te (14a ): 1H NMR
(CDCl3, 400 MHz) δ 1.80 (m, 1H), 1.98 (m, 1H), 2.04 (m, 1H),
2.08 (m, 1H), 2.95 (m, 2H), 3.46 (s, 3H), 4.40 (s, 1H), 5.42 (m,-
1H), 7.19 (d, J ) 7.6, 1H), 7.30 (t, J ) 7.6, 1H), 7.35 (om, 3H),
7.41 (td, J ) 7.6, 1.5, 1H), 7.45 (m,2H), 7.74 (dd, J ) 7.6, 1.5,
1H); 13C NMR (CDCl3, 100 MHz) δ 23.3, 28.9, 34.0, 57.5, 78.3,
82.2, 126.7, 127.3, 128.6, 128.7, 129.2, 129.9, 132.1, 136.1,
136.5, 141.4, 169.9, 199.1.
Exp er im en ta l Section
Gen er a l P r oced u r e for En ol Eth er s 2e-k , 6b-f, 8b-
d , 10b, a n d 12b. P r ep a r a tion of 4-Isop r op oxy-2H-
ch r om en e (2g). Methyl enol (2a ) (10.0 g, 61.7 mmol), 2-pro-
panol (10 mL), and p-toluenesulfonic acid monohydrate (20 mg,
1.105 mmol) were combined and heated at 80 °C for 2 h. The
temperature was increased to 110 °C allowing the low-boiling
components to distill. A concentric tube column distillation
head was used to collect 10.2 g of a clear colorless oil containing
78 mol % 2g at 112 °C and 4 Torr: 1H NMR (CDCl3, 400 MHz)
δ 1.38 (d, J ) 6.1, 6H), 4.4 (m, 1H), 4.74 (t, J ) 3.9, 1H), 4.88
(d, J ) 3.9, 2H), 6.85 (dd, J ) 8.1, 1.0, 1H), 6.95 (td, J ) 7.5,
1.1 1H), 7.19 (td, J ) 7.7, 1.7, 1H), 7.49 (dd, J ) 7.7, 1.7 1H);
13C NMR (CDCl3, 100 MHz) δ 21.8, 65.8, 69.1, 90.4, 115.6,
120.9, 121.3, 122.5, 129.6, 148.1, 155.7; GCMS m/z 190, 147,
121, 91, 65.
Su p p or tin g In for m a tion Ava ila ble: General experimen-
tal procedure, product data for compounds 2b -f, 2h -k , 7,
6a -f, 8a -d , 9, 10a ,b, 11, 12a ,b, 13, 14b, 15a ,b, and 16a ,b,
1
and copies of H and 13C NMR spectra for compounds 2-16.
This material is available free of charge via the Internet at
http://pubs.acs.org.
J O034854O
J . Org. Chem, Vol. 68, No. 21, 2003 8091